VINCU
Income statement / Annual
Last year (2023), Vincerx Pharma, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Vincerx Pharma, Inc.'s net income was -$40.16 M.
See Vincerx Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$915,000.00 |
$939,000.00 |
$340,000.00 |
$172,996.00 |
$172,996.00 |
| Gross Profit |
-$915,000.00 |
-$939,000.00 |
-$340,000.00 |
-$172,996.00 |
-$172,996.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$28.97 M
|
$52.15 M
|
$40.08 M
|
$7.12 M
|
$0.00
|
| General & Administrative
Expenses |
$13.64 M
|
$18.95 M
|
$22.58 M
|
$3.60 M
|
$54,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$44,946.00
|
| Selling, General &
Administrative Expenses |
$13.64 M
|
$18.95 M
|
$22.58 M
|
$3.60 M
|
$45,000.00
|
| Other Expenses |
$0.00 |
$1.24 M |
-$8,000.00 |
-$8,000.00 |
$0.00 |
| Operating Expenses |
$42.61 M |
$71.11 M |
$62.66 M |
$10.71 M |
$45,000.00 |
| Cost And Expenses |
$42.61 M |
$71.11 M |
$62.66 M |
$10.71 M |
$45,000.00 |
| Interest Income |
$1.25 M |
$664,000.00 |
$0.00 |
$54,266.00 |
$54,266.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$8,000.00 |
$0.00 |
| Depreciation &
Amortization |
$52,000.00
|
$939,000.00
|
$340,000.00
|
$5.71 M
|
$54,000.00
|
| EBITDA |
-$42.61 M
|
-$68.67 M
|
-$62.66 M
|
-$10.71 M
|
$9,000.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$2.45 M
|
$8.21 M
|
$23.35 M
|
-$5.91 M
|
$0.00
|
| Income Before Tax |
-$40.16 M |
-$65.37 M |
-$39.31 M |
-$10.72 M |
-$45,000.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$8.21 M |
-$23.70 M |
$8,000.00 |
-$54.00 |
| Net Income |
-$40.16 M |
-$57.16 M |
-$15.61 M |
-$10.73 M |
-$45,000.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.89 |
-2.72 |
-0.91 |
-0.77 |
-0.0087 |
| EPS Diluted |
-1.89 |
-2.72 |
-0.91 |
-0.77 |
-0.0087 |
| Weighted Average Shares
Out |
$21.30 M
|
$21.03 M
|
$17.18 M
|
$13.98 M
|
$5.20 M
|
| Weighted Average Shares
Out Diluted |
$21.30 M
|
$21.03 M
|
$17.18 M
|
$13.98 M
|
$5.20 M
|
| Link |
|
|
|
|
|
